Remacle Albert G, Shiryaev Sergey A, Oh Eok-Soo, Cieplak Piotr, Srinivasan Anupama, Wei Ge, Liddington Robert C, Ratnikov Boris I, Parent Amelie, Desjardins Roxane, Day Robert, Smith Jeffrey W, Lebl Michal, Strongin Alex Y
Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
J Biol Chem. 2008 Jul 25;283(30):20897-906. doi: 10.1074/jbc.M803762200. Epub 2008 May 27.
We present the data and the technology, a combination of which allows us to determine the identity of proprotein convertases (PCs) related to the processing of specific protein targets including viral and bacterial pathogens. Our results, which support and extend the data of other laboratories, are required for the design of effective inhibitors of PCs because, in general, an inhibitor design starts with a specific substrate. Seven proteinases of the human PC family cleave the multibasic motifs R-X-(R/K/X)-R downward arrow and, as a result, transform proproteins, including those from pathogens, into biologically active proteins and peptides. The precise cleavage preferences of PCs have not been known in sufficient detail; hence we were unable to determine the relative importance of the individual PCs in infectious diseases, thus making the design of specific inhibitors exceedingly difficult. To determine the cleavage preferences of PCs in more detail, we evaluated the relative efficiency of furin, PC2, PC4, PC5/6, PC7, and PACE4 in cleaving over 100 decapeptide sequences representing the R-X-(R/K/X)-R downward arrow motifs of human, bacterial, and viral proteins. Our computer analysis of the data and the follow-on cleavage analysis of the selected full-length proteins corroborated our initial results thus allowing us to determine the cleavage preferences of the PCs and to suggest which PCs are promising drug targets in infectious diseases. Our results also suggest that pathogens, including anthrax PA83 and the avian influenza A H5N1 (bird flu) hemagglutinin precursor, evolved to be as sensitive to PC proteolysis as the most sensitive normal human proteins.
我们展示了数据和技术,二者结合使我们能够确定与特定蛋白质靶点(包括病毒和细菌病原体)加工相关的前蛋白转化酶(PCs)的身份。我们的结果支持并扩展了其他实验室的数据,这些结果对于设计有效的PCs抑制剂是必需的,因为一般来说,抑制剂设计始于特定底物。人类PC家族的七种蛋白酶切割多碱性基序R-X-(R/K/X)-R↓,结果将前蛋白(包括病原体来源的前蛋白)转化为生物活性蛋白和肽。PCs的精确切割偏好尚未得到足够详细的了解;因此,我们无法确定个体PCs在传染病中的相对重要性,这使得设计特异性抑制剂极其困难。为了更详细地确定PCs的切割偏好,我们评估了弗林蛋白酶、PC2、PC4、PC5/6、PC7和PACE4在切割代表人类、细菌和病毒蛋白R-X-(R/K/X)-R↓基序的100多个十肽序列方面的相对效率。我们对数据的计算机分析以及对所选全长蛋白的后续切割分析证实了我们的初步结果,从而使我们能够确定PCs的切割偏好,并表明哪些PCs是传染病中有前景的药物靶点。我们的结果还表明,包括炭疽PA83和甲型禽流感H5N1(禽流感)血凝素前体在内的病原体,进化得对PC蛋白水解与最敏感的正常人类蛋白一样敏感。